Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 64 Neoplasm Metastasis 25 Kidney Neoplasms 21 Neoplasms 16 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 13 Urinary Bladder Neoplasms 12 Prostatic Neoplasms 10 Lung Neoplasms 8 Brain Neoplasms 8 Melanoma 7 Colorectal Neoplasms 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Neuroendocrine Tumors 6 Liver Neoplasms 6 Glioblastoma 6 Gastrointestinal Stromal Tumors 6 Carcinoma, Hepatocellular 6 Thyroid Neoplasms 5 Thymoma 5 Small Cell Lung Carcinoma 5 Recurrence 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Carcinoma 5 Uveal Melanoma 4 Stomach Neoplasms 4 Sarcoma 4 Adenocarcinoma 4

Interventions

pembrolizumab 6 Mitotane 5 Cisplatin 5 cabozantinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Radiotherapy 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cytoreduction Surgical Procedures 2 milademetan 1 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Tamoxifen 1 Suramin 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00453895 2019-01-31

SIRAC

University of Wuerzburg

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡